Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro

Jelena Gotovina; Rodolfo Bianchini; Judit Fazekas-Singer; Ina Herrmann; Giulia Pellizzari; Ian D. Haidl; Karin Hufnagl; Sophia N. Karagiannis; Jean S. Marshall; Erika Jensen-Jarolim

doi:10.1111/all.14299

Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro

Jelena Gotovina, Rodolfo Bianchini, Judit Fazekas-Singer, Ina Herrmann, Giulia Pellizzari, Ian D. Haidl, Karin Hufnagl, Sophia N. Karagiannis, Jean S. Marshall, Erika Jensen-Jarolim

Medicine

Résultat de recherche: Letter › examen par les pairs

6 Citations (Scopus)

Langue d'origine	English
Pages (de-à)	2939-2942
Nombre de pages	4
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	75
Numéro de publication	11
DOI	https://doi.org/10.1111/all.14299
Statut de publication	Published - nov. 1 2020

Note bibliographique

Funding Information:
This study was supported by the Austrian Science Fund grants W1205‐B09 (CCHD) and SFB F4606‐B28 to EJJ. The authors acknowledge support by the Medical Research Council (MR/L023091/1) (SNK); the Academy of Medical Sciences (SNK); CR UK//NIHR in England/DoH for Scotland, Wales and Northern Ireland Experimental Cancer Medicine Centre (C10355/A15587) (SNK); Cancer Research UK (C30122/A11527; C30122/A15774) (SNK, GP); and Breast Cancer Now (147), working in partnership with Walk the Walk (SNK). The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Guy's and St. Thomas' NHS Foundation Trust and King's College London (IS‐BRC‐1215‐20006) (SNK).

ASJC Scopus Subject Areas

Immunology and Allergy
Immunology

PubMed: MeSH publication types

Letter
Research Support, Non-U.S. Gov't

Accès au document

10.1111/all.14299

Autres fichiers et liens

Citer

Gotovina, J., Bianchini, R., Fazekas-Singer, J., Herrmann, I., Pellizzari, G., Haidl, I. D., Hufnagl, K., Karagiannis, S. N., Marshall, J. S., & Jensen-Jarolim, E. (2020). Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro. Allergy: European Journal of Allergy and Clinical Immunology, 75(11), 2939-2942. https://doi.org/10.1111/all.14299

Gotovina, J, Bianchini, R, Fazekas-Singer, J, Herrmann, I, Pellizzari, G, Haidl, ID, Hufnagl, K, Karagiannis, SN, Marshall, JS & Jensen-Jarolim, E 2020, 'Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro', Allergy: European Journal of Allergy and Clinical Immunology, vol. 75, n° 11, pp. 2939-2942. https://doi.org/10.1111/all.14299

@article{b265b6f3220f44b8aa1051475b093028,

title = "Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro",

author = "Jelena Gotovina and Rodolfo Bianchini and Judit Fazekas-Singer and Ina Herrmann and Giulia Pellizzari and Haidl, {Ian D.} and Karin Hufnagl and Karagiannis, {Sophia N.} and Marshall, {Jean S.} and Erika Jensen-Jarolim",

note = "Funding Information: This study was supported by the Austrian Science Fund grants W1205‐B09 (CCHD) and SFB F4606‐B28 to EJJ. The authors acknowledge support by the Medical Research Council (MR/L023091/1) (SNK); the Academy of Medical Sciences (SNK); CR UK//NIHR in England/DoH for Scotland, Wales and Northern Ireland Experimental Cancer Medicine Centre (C10355/A15587) (SNK); Cancer Research UK (C30122/A11527; C30122/A15774) (SNK, GP); and Breast Cancer Now (147), working in partnership with Walk the Walk (SNK). The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Guy's and St. Thomas' NHS Foundation Trust and King's College London (IS‐BRC‐1215‐20006) (SNK).",

year = "2020",

month = nov,

day = "1",

doi = "10.1111/all.14299",

language = "English",

volume = "75",

pages = "2939--2942",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell",

number = "11",

}

TY - JOUR

T1 - Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro

AU - Gotovina, Jelena

AU - Bianchini, Rodolfo

AU - Fazekas-Singer, Judit

AU - Herrmann, Ina

AU - Pellizzari, Giulia

AU - Haidl, Ian D.

AU - Hufnagl, Karin

AU - Karagiannis, Sophia N.

AU - Marshall, Jean S.

AU - Jensen-Jarolim, Erika

N1 - Funding Information: This study was supported by the Austrian Science Fund grants W1205‐B09 (CCHD) and SFB F4606‐B28 to EJJ. The authors acknowledge support by the Medical Research Council (MR/L023091/1) (SNK); the Academy of Medical Sciences (SNK); CR UK//NIHR in England/DoH for Scotland, Wales and Northern Ireland Experimental Cancer Medicine Centre (C10355/A15587) (SNK); Cancer Research UK (C30122/A11527; C30122/A15774) (SNK, GP); and Breast Cancer Now (147), working in partnership with Walk the Walk (SNK). The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Guy's and St. Thomas' NHS Foundation Trust and King's College London (IS‐BRC‐1215‐20006) (SNK).

PY - 2020/11/1

Y1 - 2020/11/1

UR - http://www.scopus.com/inward/record.url?scp=85083509158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083509158&partnerID=8YFLogxK

U2 - 10.1111/all.14299

DO - 10.1111/all.14299

M3 - Letter

C2 - 32246841

AN - SCOPUS:85083509158

SN - 0105-4538

VL - 75

SP - 2939

EP - 2942

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 11

ER -